Novel heterozygous VPS13A pathogenic variants in chorea-neuroacanthocytosis: a case report

BMC Neurol. 2023 Oct 4;23(1):350. doi: 10.1186/s12883-023-03398-x.

Abstract

Background: Chorea-acanthocytosis (ChAc) is a rare hereditary autosomal recessive neurodegenerative disorder caused by pathogenic variants of the Vacuolar Protein Sorting 13 homolog A (VPS13A) gene. The variant spectrum of VPS13A has not been completely elucidated. This study reports two novel heterozygous VPS13A pathogenic variants in ChAc that expand the variant spectrum of VPS13A.

Case presentation: We described a case of a 29-year-old man with typical clinical manifestations of ChAc, including chorea, orofacial lingual dyskinesia, vocal tics, elevated serum biochemical indicators, increased acanthocytes in peripheral blood, and caudate nucleus atrophy. Next-generation sequencing revealed two heterozygous variants of VPS13A: a nonsense variant (NM_033305.2: c.8215G > T, p. Glu2739Ter) and a deletion variant in the exons 25-31.

Conclusion: The identified nonsense variant gives rise to premature translation termination, while the deletion variant is expected to cause a significant in-frame deletion of amino acid residues in the encoded protein. Both variants are considered to be pathogenic and result in loss-of-function proteins. These findings have implications for the genetic counseling of patients with VPS13A variants.

Keywords: Chorea; Movement disorders; Neuroacanthocytosis; VPS13A.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Caudate Nucleus / metabolism
  • Caudate Nucleus / pathology
  • Dyskinesias*
  • Humans
  • Male
  • Neuroacanthocytosis* / genetics
  • Tics*
  • Vesicular Transport Proteins / genetics

Substances

  • Vesicular Transport Proteins
  • VPS13A protein, human